AroCell AB (Sweden) Analysis
| AROC Stock | SEK 0.40 0.03 6.98% |
AroCell AB is fairly valued with Real Value of 0.38 and Hype Value of 0.4. The main objective of AroCell AB stock analysis is to determine its intrinsic value, which is an estimate of what AroCell AB is worth, separate from its market price. There are two main types of AroCell AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AroCell AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AroCell AB's stock to identify patterns and trends that may indicate its future price movements.
The AroCell AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. AroCell AB is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. AroCell Stock trading window is adjusted to Europe/Stockholm timezone.
AroCell |
AroCell Stock Analysis Notes
About 42.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. AroCell AB recorded a loss per share of 0.5. The entity had not issued any dividends in recent years. AroCell AB , a vitro diagnostics company, focuses on the monitoring of hematological malignancies, breast cancer, and other solid tumors. AroCell AB was founded in 2003 and is based in Uppsala, Sweden. AroCell AB is traded on Stockholm Stock Exchange in Sweden. For more info on AroCell AB please contact the company at 46 18 50 30 20 or go to https://www.arocell.com.AroCell AB Investment Alerts
| AroCell AB generated a negative expected return over the last 90 days | |
| AroCell AB has some characteristics of a very speculative penny stock | |
| AroCell AB has high historical volatility and very poor performance | |
| The company reported the revenue of 12 M. Net Loss for the year was (50.02 M) with loss before overhead, payroll, taxes, and interest of (5.04 M). | |
| AroCell AB has accumulated about 21.43 M in cash with (28.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 42.0% of the company shares are held by company insiders |
AroCell Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 152.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AroCell AB's market, we take the total number of its shares issued and multiply it by AroCell AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.AroCell Profitablity
AroCell AB's profitability indicators refer to fundamental financial ratios that showcase AroCell AB's ability to generate income relative to its revenue or operating costs. If, let's say, AroCell AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AroCell AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AroCell AB's profitability requires more research than a typical breakdown of AroCell AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.07. Technical Drivers
As of the 30th of November, AroCell AB shows the Risk Adjusted Performance of (0.13), standard deviation of 3.07, and Mean Deviation of 2.25. AroCell AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.AroCell AB Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AroCell AB middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AroCell AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
AroCell AB Outstanding Bonds
AroCell AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AroCell AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AroCell bonds can be classified according to their maturity, which is the date when AroCell AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
AroCell AB Predictive Daily Indicators
AroCell AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AroCell AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
AroCell AB Forecast Models
AroCell AB's time-series forecasting models are one of many AroCell AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AroCell AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About AroCell Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how AroCell AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AroCell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AroCell AB. By using and applying AroCell Stock analysis, traders can create a robust methodology for identifying AroCell entry and exit points for their positions.
AroCell AB , a vitro diagnostics company, focuses on the monitoring of hematological malignancies, breast cancer, and other solid tumors. AroCell AB was founded in 2003 and is based in Uppsala, Sweden. AroCell AB is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AroCell AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Additional Tools for AroCell Stock Analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.